979094

Alexion Pharmaceuticals, Inc. — FEI 3006031727

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
June 27, 2016
Fiscal Year
2016
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
New Haven, CT (United States)

Additional Details

Risk Evaluation and Mitigation Strategies (REMS)